Real-time PCR

Today R-Biopharm launches the new RIDA®GENE SARS-CoV-2 RUO test for the detection of coronavirus SARS-CoV-2 from human respiratory samples.

On December 31st, 2019, the World Health Organization (WHO) was informed of several cases of severe pneumonia in the Chinese metropolis of Wuhan City, caused by a previously unknown virus.

Real-time PCR tests offer many advantages and have become an important part of clinical diagnostics. Yet the efficiency of the tests depends also on the software. With the new, automated [...]

As temperatures grow colder, the risk of catching the flu virus and spreading the infection among the population rises as well. But what makes the influenza virus so dangerous? For Virus [...]

Very few know it and yet most people carry it: cytomegalovirus. While the infection is usually asymptomatic in healthy people, newborns and patients with immune deficiencies can experience [...]

aprimeo diagnostics GmbH & Co. KG, a R-Biopharm AG company, starts distribution of the new innovative molecular diagnostics platform Vivalytic from Bosch

Five percent of people in Germany suffer from a rare disease. On the occasion of Rare Disease Day, February 28th, 2019, we will take a closer look at one of them.

An estimated 540 million people worldwide suffer from lower back pain. When the pain becomes chronic, a rheumatic illness such as Bechterew’s disease may be the cause.

The year’s wet and cold season begins in October along with the annual flu season. After an extraordinarily severe flu wave in 2017/18, experts are warning that the flu should not be [...]

The new generation of the RIDA®GENE multiplex real-time PCR kits offers a number of improvements—and makes molecular laboratory diagnostics even more efficient and flexible.